Vincerx Pharma, Inc.

VINC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,987$12,782$11,663$111,459
Short-Term Investments$0$0$40,796$0
Receivables$1,041$1,044$1,372$0
Inventory$0$0$0$0
Other Curr. Assets$382$907$2,133$382
Total Curr. Assets$6,410$14,733$55,964$111,841
Property Plant & Equip (Net)$0$2,326$3,241$4,182
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,595$1,158$81$1,653
Total NC Assets$1,595$3,484$3,322$5,835
Other Assets$0$0$0$0
Total Assets$8,005$18,217$59,286$117,676
Liabilities
Payables$2,029$2,497$4,065$2,019
Short-Term Debt$0$1,162$2,048$1,476
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$4,715
Other Curr. Liab.$3,252$1,946$3,043$5,709
Total Curr. Liab.$5,281$5,605$9,156$13,919
LT Debt$0$1,340$2,412$3,436
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$50$50$0
Total NC Liab.$0$1,390$2,462$3,436
Other Liabilities$0$0$0$0
Cap. Leases$0$2,502$3,436$4,174
Total Liabilities$5,281$6,995$11,618$17,355
Equity
Pref Stock$0$0$0$0
Common Stock$8$2$2$2
Retained Earnings-$189,186-$159,112-$118,955-$55,971
AOCI$119$8-$26-$21
Other Equity$191,791$170,324$166,647$156,311
Total Equity$2,724$11,222$47,668$100,321
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$8,005$18,217$59,286$117,676
Net Debt-$4,987-$10,280-$7,203-$106,547